How to read: Every bubble is one Indian trimethoprim exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Trimethoprim report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial trimethoprim trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian trimethoprim suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Trimethoprim India trade report
P
Product scope
Trimethoprim
All variants merged — branded and generic formulations of trimethoprim
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
127
Every commercial trimethoprim trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $214.5K, Nov $93.4K, Dec $686.9K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$214.5K
Oct USD
10 shipments
2
$93.4K
Nov USD
-56.4% MoM
3
$686.9K
Dec USD
+635.4% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 56.4% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $214K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MICRO LABS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import trimethoprim from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited Kingdom absorbs 42.3% of India’s 2025-Q4 trimethoprim trade ($420.5K). Beyond the top 10 destinations, 29 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 15 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 29 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much trimethoprim India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$53K
5.4% of trade
6 countries · 70 shipments
Europe
$474K
47.6% of trade
2 countries · 9 shipments
Americas
$39K
3.9% of trade
5 countries · 10 shipments
Africa
$428K
43.1% of trade
15 countries · 36 shipments
Oceania
$219
0.0% of trade
2 countries · 2 shipments
Fig 4.1 United Kingdom is the #1 corridor ($421K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian trimethoprim it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United Kingdom
$421K
7
FLAMINGO PHARMACEUTICALS LTD
$400K
PROSFORA TECHNOLOGIES PVT LTD
$21K
—
—
2
Republic of the Congo
$113K
3
MICRO LABS LTD
$113K
—
—
—
—
3
Senegal
$99K
9
GRASETH MEDICARE PVT LTD
$52K
ZENKO LIFE SCIENCE LLP
$47K
—
—
4
Tanzania
$94K
1
ZYDUS LIFESCIENCES LTD
$94K
—
—
—
—
5
France
$53K
2
MEDREICH LTD
$53K
—
—
—
—
6
Uzbekistan
$29K
1
GOD GIFT LABORATORY PVT LTD
$29K
—
—
—
—
7
Kenya
$25K
3
LABORATE PHARMACEUTICALS INDIA LTD
$20K
JB BIOELAN
$5K
—
—
8
Angola
$21K
3
LABORATE PHARMACEUTICALS INDIA LTD
$14K
ZENKO LIFE SCIENCE LLP
$7K
—
—
9
Guatemala
$20K
2
CAPLIN POINT LABORATORIES LTD
$15K
BALAXI PHARMACEUTICALS LTD
$5K
—
—
10
Dominican Republic
$19K
4
BALAXI PHARMACEUTICALS LTD
$10K
SSKY INTERNATIONAL
$9K
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 5.4% of USD — but United Kingdom is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
42.3%
#1 country share
United Kingdom alone
78.5%
Top 5 share
5 of 30 countries
97.0%
Top 15 share
Long tail of 15 countries = 3.0%
HHI 2173
Destination HHI
Moderately concentrated
30
Countries served
Global pharma reach from India
15
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
37 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYFLAMINGO PHARMACEUTICALS LTD ($399.9K, 40.2% share) and MICRO LABS LTD ($122.2K) together control 52.5% of India’s 2025-Q4 trimethoprim trade. The top 5 suppliers hold 72.8%. 37 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian trimethoprim suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 FLAMINGO PHARMACEUTICALS LTD leads by $278K over MICRO LABS LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MEDICAMEN BIOTECH LTD is #15 by value but #4 by volume.
Fig 5.2 ZENKO LIFE SCIENCE LLP also leads by shipment count (9) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MEDICAMEN BIOTECH LTD moves from #4 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 37 trimethoprim suppliers split into strategic segments
KEY TAKEAWAY10 suppliers (25%) generate 88.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 FLAMINGO PHARMACEUTICALS LTD and MICRO LABS LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 88.1% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 30 countries — who is buying Indian trimethoprim and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 90.3% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian trimethoprim. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 KENT PHARMA UK LTD is the #1 importer at $400K (40.2%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian trimethoprim prices vary by supplier, country and dosage form
KEY TAKEAWAYTrimethoprim prices span 762660× ($0.0002 → $173.73). The coefficient of variation is 6.11. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. PROSFORA TECHNOLOGIES PVTSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. FLAMINGO PHARMACEUTICALS LTDSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. CAPLIN POINT LABORATORIESSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. ZYDUS LIFESCIENCES LTDSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
SYNCOM FORMULATI…
Cameroon
Tablet
48
$9K
$186.43
Specialty / small-batch
Oct 2025
GRASETH MEDICARE…
Senegal
Tablet
300
$52K
$173.73
Specialty / small-batch
Dec 2025
MEDREICH LTD
France
Tablet
967
$23K
$24.13
Specialty / small-batch
Nov 2025
ZENKO LIFE SCIEN…
Angola
Tablet
686
$7K
$10.56
Specialty / small-batch
Dec 2025
ZENKO LIFE SCIEN…
Senegal
Tablet
1K
$10K
$9.33
Specialty / small-batch
Dec 2025
ZENKO LIFE SCIEN…
Senegal
Tablet
711
$7K
$9.24
Specialty / small-batch
Dec 2025
ZENKO LIFE SCIEN…
Senegal
Tablet
711
$7K
$9.23
Specialty / small-batch
Dec 2025
MICRO LABS LTD
Republic of the Congo
Tablet
3K
$19K
$6.67
Specialty / small-batch
Dec 2025
MICRO LABS LTD
Republic of the Congo
Tablet
6K
$37K
$6.67
Specialty / small-batch
Dec 2025
MICRO LABS LTD
Republic of the Congo
Tablet
9K
$58K
$6.67
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
TORRENT PHARMACE…
Brazil
Suspension
171K
$174.35
$0.0010
Dec 2025
MOVID IMPEX
United Arab Emirates
Tablet
9
$0.013
$0.0015
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
96
$0.245
$0.0026
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
153
$0.391
$0.0026
Bulk generic tablet
Dec 2025
DERRIC WOOD
United Arab Emirates
Tablet
177
$0.453
$0.0026
Bulk generic tablet
Dec 2025
PREMIER ENTERPRISE
United Arab Emirates
Tablet
10
$0.026
$0.0026
Bulk generic tablet
Dec 2025
MEDICAMEN BIOTEC…
Ethiopia
Suspension
60K
$187.93
$0.0031
Dec 2025
MEDICAMEN BIOTEC…
Ethiopia
Suspension
290K
$909.12
$0.0031
Dec 2025
MEDICAMEN BIOTEC…
Ethiopia
Suspension
194K
$606.38
$0.0031
Dec 2025
MEDICAMEN BIOTEC…
Ethiopia
Suspension
88K
$276.88
$0.0031
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship trimethoprim, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYTrimethoprim leaves India through 11+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), BANGALORE AIR, MUNDRA SEA) handle 93.4% of total USD. SEA moves 31% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $657K — top 11 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 31% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$730K
73.3% of USD · 30.7% of ships
AIR
$160K
16.1% of USD · 62.2% of ships
ICD
$105K
10.6% of USD · 7.1% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Europe ($415K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYMaldives is the most concentrated destination (HHI 10000, 1 suppliers). South Africa is the most competitive (HHI 0).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Maldives (HHI 10,000) is the most concentrated — Dominican Republic (HHI 5,007) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
KENT PHARMA UK LTD
United Kingdom
FLAMINGO PHARMAC…
$400K
5
HIGH
BUREAU DU PNUD
Republic of the Congo
MICRO LABS LTD
$113K
3
HIGH
ABACUS PHARMA (A) LTD
Tanzania
ZYDUS LIFESCIENC…
$94K
1
MEDIUM
LABORATOIRE BAILLY C…
France
MEDREICH LTD
$53K
2
MEDIUM
M&L PHARMACEUTIQUE S…
Senegal
GRASETH MEDICARE…
$52K
1
MEDIUM
UNIMED SARL
Senegal
ZENKO LIFE SCIEN…
$47K
8
MEDIUM
SMART-PHARMO LLC
Uzbekistan
GOD GIFT LABORAT…
$29K
1
MEDIUM
DRUGSRUS LTD
United Kingdom
PROSFORA TECHNOL…
$21K
2
MEDIUM
Conclusion: 30 buyers depend on exactly one Indian supplier, representing $898K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
5
$23
PREMIER ENTERP…
HIGH
Conclusion: 1 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United Kingdom
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Republic of the Congo
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Senegal
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Uzbekistan
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Angola
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Guatemala
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Dominican Republic
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Tajikistan
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Sierra Leone
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Somalia
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Ethiopia
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Equatorial Guinea
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United Kingdom
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Maldives lock-ins (HHI 10000)
This Q
MED
A5
Enter United Kingdom (2 suppliers)
This Q
HIGH
A6
Enter Republic of the Congo (1 suppliers)
This Q
MED
A8
Build Republic of the Congo distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (MICRO LABS)
This Q
MED
A7
Register for United Kingdom tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United Kingdom
Other
2
$421K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
2
Republic of the Congo
Africa
1
$113K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Senegal
Africa
2
$99K
-28.1%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
4
Tanzania
Africa
1
$94K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
France
Other
1
$53K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Uzbekistan
Asia
1
$29K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Kenya
Africa
2
$25K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
8
Angola
Africa
2
$21K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
Guatemala
Other
2
$20K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Dominican Republic
Other
2
$19K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
11
Tajikistan
Asia
1
$17K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Sierra Leone
Africa
1
$17K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Somalia
Africa
1
$15K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Ethiopia
Africa
1
$13K
-82.4%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Equatorial Guinea
Africa
1
$9K
-98.3%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 127 2025-Q4 Trimethoprim shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/trimethoprim
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 127 2025-Q4 trimethoprim shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian trimethoprim shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
127
across all regions
TOTAL USD
$995K
2025-Q4 FOB value
UNITS
2.9M
tablets, capsules, etc.
SUPPLIERS
37
Indian exporters
BUYERS
33
global importers
COUNTRIES
30
destinations
§10.2 Regional breakdown
Africa
$428K
43.1%
15 ctry · 36 ships
Asia
$53K
5.4%
6 ctry · 70 ships
Europe
$474K
47.6%
2 ctry · 9 ships
Americas
$39K
3.9%
5 ctry · 10 ships
Oceania
$219.20
0.0%
2 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $428K (43.1%), spanning 15 countries.
🏢
37 Indian suppliers shipped to 33 buyers across 30 countries — average shipment value $8K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 31 global trimethoprim importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian trimethoprim in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
KENT PHARMA UK LTD
United Kingdom
5
$400K
FLAMINGO PHARMACEUTI…
Tablet
2
BUREAU DU PNUD
Republic of the Congo
3
$113K
MICRO LABS LTD
Tablet
3
ABACUS PHARMA (A) LTD
Tanzania
1
$94K
ZYDUS LIFESCIENCES LTD
Tablet
4
LABORATOIRE BAILLY CREAT
France
2
$53K
MEDREICH LTD
Tablet
5
M&L PHARMACEUTIQUE SARL
Senegal
1
$52K
GRASETH MEDICARE PVT…
Tablet
6
UNIMED SARL
Senegal
8
$47K
ZENKO LIFE SCIENCE LLP
Syrup, Oral Solution, Tablet
7
SMART-PHARMO LLC
Uzbekistan
1
$29K
GOD GIFT LABORATORY …
Tablet
8
DRUGSRUS LTD
United Kingdom
2
$21K
PROSFORA TECHNOLOGIE…
Tablet
9
QUALITY HEALTHCARE COMPANY (SL) LTD
Sierra Leone
1
$17K
RONAK EXIM PVT LTD
Tablet
10
FARMA SOLUTION, SOCIEDAD ANNIMA
Guatemala
1
$15K
CAPLIN POINT LABORAT…
Tablet
11
BALAXI HEALTHCARE DOMINICANA SRL
Dominican Republic
3
$10K
BALAXI PHARMACEUTICA…
12
GOVERNMENT OF EQUATORIAL
Equatorial Guinea
1
$9K
MICRO LABS LTD
Tablet
13
TRADEMAX COMERCIO GERAL (SU),LDA
Angola
1
$7K
ZENKO LIFE SCIENCE LLP
Tablet
14
MEDVIN PHARMA LTD
Uganda
1
$6K
LEBEN LABORATORIES P…
Tablet
15
GITTOES PHARMACEUTICALS SOUTH SUDAN
Kenya
2
$5K
JB BIOELAN
Suspension
16
BALAXI HEALTHCARE GUATEMALA, S.A
Guatemala
1
$5K
BALAXI PHARMACEUTICA…
Tablet
17
MAPUTO HEALTH CARE LDA
Mozambique
2
$5K
KAUSIKH THERAPEUTICS…
Tablet
18
RAHMAN WALI LTD
Afghanistan
1
$4K
ARBRO PHARMACEUTICAL…
Suspension
19
PHARMAVET LTD
Malawi
1
$2K
LEBEN LABORATORIES P…
Tablet
20
BMS TIBBI MALZEMELER VE ILAC ITHALA
Turkey
1
$2K
M T MADON EXPORTS
Tablet
21
EMIRATES POST COMPANY
United Arab Emirates
26
$855.73
DERRIC WOOD
Tablet, Suspension
22
SEYDOU SA
Benin
1
$463.46
OSAKA PHARMACEUTICAL…
Tablet
23
REPUBLIC OF NAURU - DEPARTMENT OF H
Nauru
1
$189.20
HLL LIFECARE LTD
Tablet
24
TORRENT DO BRASIL LTDA
Brazil
1
$174.35
TORRENT PHARMACEUTIC…
Suspension
25
UNDP GUINEA EQUATORIAL
Equatorial Guinea
1
$149.43
MICRO LABS LTD
Tablet
26
TREE TOP HEALTH PVT LTD
Maldives
8
$36.03
MC PHARMA DISTRIBUTORS
Tablet
27
EMIRATES POST GROUP
United Arab Emirates
21
$22.92
PREMIER ENTERPRISE
Tablet
28
FOR THE ORDER OF
Antigua and Barbuda
1
$15.05
3S CORP
Tablet
29
TISHEENA ROACH (BSO)
Jamaica
1
$11.99
JEEDNYA PHARMA
Tablet
30
DONNA AMEER (BSO)
Jamaica
1
$7.92
JEEDNYA PHARMA
Tablet
31
RGCO (PTY) LTD
South Africa
1
$0.0000
AGOG PHARMA LTD
Tablet
This report covers 127 2025-Q4 Trimethoprim shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/trimethoprim
Talk to our trade analyst
Need a custom trimethoprim report or a deeper dive into any market? Our team is ready.